HC Wainwright & Co. analyst Joseph Pantginis downgrades Applied Genetic Techs (NASDAQ:AGTC) from Buy to Neutral.
HC Wainwright & Co. Downgrades Applied Genetic Techs to Neutral
HC Wainwright & Co. analyst Joseph Pantginis downgrades Applied Genetic Techs (NASDAQ:AGTC) from Buy to Neutral.
Related Posts
CapStar Financial Hldgs Q3 EPS $0.37 Misses $0.47 Estimate, Sales $28.82M Miss $31.86M Estimate
CapStar Financial Hldgs (NASDAQ:CSTR) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.47 by 21.28 percent. This is a 37.29 percent decrease over earnings of $0.59 per
Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday.
NeuroOne Medical Technologies As Of September 30, 2022, The Company Had Cash, Cash Equivalents, And Short-Term Investments Of $11.1M. The Company Had No Debt Outstanding As Of September 30, 2022
Fourth Quarter and Recent Business Highlights
Received a $3.5 million accelerated payment from distribution partner Zimmer Biomet related to certain milestone events; Zimmer Biomet received a Warrant to